Найдите нужного вам CMO/CDMO

ТЕРАПЕВТИЧЕСКИЕ ОБЛАСТИ ЭКСПЕРТИЗЫ (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

OEB (диапазон профессионального воздействия): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

РЫНКИ: NMPA (China), FDA (USA)

ОБЛАСТЬ: Азиатско-Тихоокеанский регион

СОГЛАСИЕ: FDA (cGMP), ISO, NMPA (China GMP)

РАЗМЕР ПАРТИИ: Large, Small, Medium

ИСПОЛЬЗОВАТЬ: Human, Veterinary

КАТЕГОРИЯ/ПРОДУКТ: ХИМИКО-СИНТЕТИЧЕСКИЙ

УСЛУГИ: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

ТЕРАПЕВТИЧЕСКИЕ ОБЛАСТИ ЭКСПЕРТИЗЫ (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

КОНТРОЛИРУЕМЫЕ ВЕЩЕСТВА: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

РЫНКИ: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

ОБЛАСТЬ: Европа

СОГЛАСИЕ: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

РАЗМЕР ПАРТИИ: Large, Small, Medium

ИСПОЛЬЗОВАТЬ: Human, Veterinary

КАТЕГОРИЯ/ПРОДУКТ: ХИМИКО-СИНТЕТИЧЕСКИЙ

УСЛУГИ: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (диапазон профессионального воздействия): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

ТЕРАПЕВТИЧЕСКИЕ ОБЛАСТИ ЭКСПЕРТИЗЫ (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

КОНТРОЛИРУЕМЫЕ ВЕЩЕСТВА: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

РЫНКИ: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea), TGA (Australia)

СОГЛАСИЕ: FDA (cGMP), ISO, ECOVADIS

РАЗМЕР ПАРТИИ: Large, Small, Medium

ИСПОЛЬЗОВАТЬ: Human, Veterinary

КАТЕГОРИЯ/ПРОДУКТ: ХИМИКО-СИНТЕТИЧЕСКИЙ

УСЛУГИ: Development services, Manufacturing services

OEB (диапазон профессионального воздействия): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

ОБЛАСТЬ: Северная Америка

РЫНКИ: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

УСЛУГИ: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

ОБЛАСТЬ: Европа

СОГЛАСИЕ: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

РАЗМЕР ПАРТИИ: Large, Small, Medium

ИСПОЛЬЗОВАТЬ: Human, Veterinary

BSL (уровень биологической безопасности): 1, 2

OEB (диапазон профессионального воздействия): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

КАТЕГОРИЯ/ПРОДУКТ: БИОЛОГИЯ, ФДФ / ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ

РЫНКИ: EMA (EU), MHRA (UK), TGA (Australia)

ОБЛАСТЬ: Европа

ИСПОЛЬЗОВАТЬ: Human, Veterinary

BSL (уровень биологической безопасности): 1

УСЛУГИ: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

OEB (диапазон профессионального воздействия): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

РАЗМЕР ПАРТИИ: Small, Medium

СОГЛАСИЕ: EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

КАТЕГОРИЯ/ПРОДУКТ: ФДФ / ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ

BSL (уровень биологической безопасности): 3, 1, 2

РЫНКИ: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

УСЛУГИ: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

СОГЛАСИЕ: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)

РАЗМЕР ПАРТИИ: Large, Small, Medium

ИСПОЛЬЗОВАТЬ: Human, Veterinary

КОНТРОЛИРУЕМЫЕ ВЕЩЕСТВА: Lowest potential for abuse

OEB (диапазон профессионального воздействия): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

ОБЛАСТЬ: Северная Америка

КАТЕГОРИЯ/ПРОДУКТ: ФДФ / ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ

РЫНКИ: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)

УСЛУГИ: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

ОБЛАСТЬ: Европа

СОГЛАСИЕ: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

РАЗМЕР ПАРТИИ: Large, Small, Medium

ИСПОЛЬЗОВАТЬ: Human, Veterinary

BSL (уровень биологической безопасности): 1, 2

КАТЕГОРИЯ/ПРОДУКТ: БИОЛОГИЯ

РЫНКИ: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)

УСЛУГИ: Logistics, Development services, Manufacturing services, Analytical / QC services, Regulatory services

ОБЛАСТЬ: Европа

СОГЛАСИЕ: ISO

BSL (уровень биологической безопасности): 1

РАЗМЕР ПАРТИИ: Small, Medium

КАТЕГОРИЯ/ПРОДУКТ: БИОЛОГИЯ

РЫНКИ: EMA (EU), FDA (USA), ANVISA (Brazil), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)

УСЛУГИ: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

ОБЛАСТЬ: Европа

СОГЛАСИЕ: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

РАЗМЕР ПАРТИИ: Large, Small, Medium

ИСПОЛЬЗОВАТЬ: Human, Veterinary

ТЕРАПЕВТИЧЕСКИЕ ОБЛАСТИ ЭКСПЕРТИЗЫ (ATC): (C) Cardiovascular system, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism

КОНТРОЛИРУЕМЫЕ ВЕЩЕСТВА: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (диапазон профессионального воздействия): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

КАТЕГОРИЯ/ПРОДУКТ: ФДФ / ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ

OEB (диапазон профессионального воздействия): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

КОНТРОЛИРУЕМЫЕ ВЕЩЕСТВА: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

РЫНКИ: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

УСЛУГИ: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

ОБЛАСТЬ: Европа

СОГЛАСИЕ: ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

РАЗМЕР ПАРТИИ: Large, Small, Medium

ИСПОЛЬЗОВАТЬ: Human

BSL (уровень биологической безопасности): 1, 2

ТЕРАПЕВТИЧЕСКИЕ ОБЛАСТИ ЭКСПЕРТИЗЫ (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (N) Nervous system

КАТЕГОРИЯ/ПРОДУКТ: ФДФ / ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ

РЫНКИ: EMA (EU)

ОБЛАСТЬ: Европа

СОГЛАСИЕ: ISO, EMA (EU GMP)

РАЗМЕР ПАРТИИ: Large, Medium

КАТЕГОРИЯ/ПРОДУКТ: НУТРАЦЕВТИКИ, ФДФ / ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ

ИСПОЛЬЗОВАТЬ: Veterinary

УСЛУГИ: Manufacturing services, Analytical / QC services, Regulatory services, Packaging

КОНТРОЛИРУЕМЫЕ ВЕЩЕСТВА: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

СОГЛАСИЕ: ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)

РЫНКИ: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MFDS (South Korea), TGA (Australia)

РАЗМЕР ПАРТИИ: Large, Medium

ИСПОЛЬЗОВАТЬ: Human

КАТЕГОРИЯ/ПРОДУКТ: ХИМИКО-СИНТЕТИЧЕСКИЙ, УСЛУГИ, ФДФ / ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ, ЧАСТИЦИЧНАЯ ИНЖИНИРИНГИЯ

УСЛУГИ: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

ТЕРАПЕВТИЧЕСКИЕ ОБЛАСТИ ЭКСПЕРТИЗЫ (ATC): (C) Cardiovascular system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (S) Sensory organs, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

ОБЛАСТЬ: Северная Америка

OEB (диапазон профессионального воздействия): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)